Image may be NSFW.
Clik here to view.
The FDA has placed an indefinite hold on implementing new regulations relating to how the agency determines a medical product’s intended use.
The decision to press pause on the new rules drew cheers from the medical device and pharmaceutical industries, after companies voiced their concerns last year that the proposed changes were unclear.
Get the full story at our sister site, Drug Delivery Business News.
The post FDA kicks the can on off-label marketing appeared first on MassDevice.
